Case Study | Sale of Rocky Mountain Movement Disorders Center

Share This Post

Objective, Investment Banking & Valuation (“Objective”), an award-winning middle market investment banking and valuation firm, is pleased to announce that it served as the exclusive sell-side financial advisor to Rocky Mountain Movement Disorders Center (“CenExel RMCR”) in its sale of its clinical research site operations to CenExel Clinical Research, Inc. (“CenExel”).

CenExel RMCR serves one of the largest communities of patients with Parkinson’s disease and other movement disorders in Colorado. The company offers comprehensive and customized treatment plans for their patients to have the highest quality of life.

The CenExel Centers of Excellence network now comprises 13 highly accomplished clinical research sites in the United States, with concentration on Neurology, Pain, Psychiatry, Vaccines/Immunology, Dermatology, Ethnic-bridging, Sleep studies, and Clinical Pharmacology. Each of the CenExel research units has an outstanding record of excellence assisting pharmaceutical sponsors with protocol development, study design, and conducting Phase I-IV trials to develop new therapeutics for improved patient care.

Read the full press release

 

If you would like to discuss your own transaction goals contact the Managing Directors from our Life Sciences Services & Tech Practice, or reach out at (800) 849-7010 or [email protected] to be directed to the appropriate team member.

Disclosure

The above testimonials may not be representative of the experience of other customers and past performance is not a guarantee of future performance or success.

This news release is for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC make no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. All information contained herein is preliminary, limited and subject to completion, correction or amendment. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person. Securities and investment banking services are offered through BA Securities, LLC Member FINRA, SIPC. Principals of Objective Capital are Registered Representatives of BA Securities. Objective Capital Partners and BA Securities are separate and unaffiliated entities.

More Posts